Pro-Dex (co) (PDEX) has a profit margin of 16.08%, above the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for PDEX is 16.08% as of March 2026. That compares with 14.61% in the prior-year period — up 10.1% year over year. That is above the Healthcare sector average of 15.58%. Investors often review this figure alongside Pro-Dex (co)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, PDEX's profit margin moved from 14.61% to 16.08% — a 10.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pro-Dex (co)'s valuation or profitability profile.
Against Healthcare companies, PDEX currently prints 16.08% for profit margin, while the sector average sits near 15.58%. That is roughly 3.2% above the sector mean. Large gaps often invite a closer look at Pro-Dex (co)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Pro-Dex (co) converts resources into returns. At 16.08%, PDEX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14.61% in the prior-year period — up 10.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PDEX's profit margin (16.08%), review year-over-year change from 14.61%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.